| Income Statement |
| Operating Expenses | 7.24M |
|
| Research and Development Expense | 5.41M |
| Selling, General and Administrative Expense | 1.84M |
| Operating Income | -7.24M |
| Net Income | -7.36M |
| Net Income Common Stock | -7.36M |
| Net Income Common Stock (USD) | -7.36M |
| Consolidated Income | -7.36M |
| Earnings per Basic Share | -3.30 |
| Earnings per Basic Share (USD) | -3.30 |
| Earnings per Diluted Share | -3.30 |
| Earning Before Interest & Taxes (EBIT) | -7.36M |
| Earning Before Interest & Taxes (USD) | -7.36M |
| Weighted Average Shares | 2.20M |
| Weighted Average Shares Diluted | 2.20M |
| Balance Sheet |
| Cash and Equivalents | 2.94M |
| Cash and Equivalents (USD) | 2.94M |
| Current Assets | 3.47M |
| Property, Plant & Equipment Net | 6.79M |
| Total Assets | 10.26M |
| Debt Current | 464.00K |
| Total Debt | 504.00K |
| Current Liabilities | 2.18M |
| Debt Non-Current | 40.00K |
| Total Liabilities | 4.38M |
| Accumulated Retained Earnings (Deficit) | -106.60M |
| Shareholders Equity | 5.88M |
| Shareholders Equity (USD) | 5.88M |
| Assets Non-Current | 6.79M |
| Total Debt (USD) | 504.00K |
| Liabilities Non-Current | 2.20M |
| Trade and Non-Trade Payables | 1.01M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 430.00K |
| Net Cash Flow from Financing | 6.00M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.38M |
| Capital Expenditure | -1.22M |
| Issuance (Purchase) of Equity Shares | 6.00M |
| Net Cash Flow from Investing | -1.22M |
| Net Cash Flow from Operations | -7.15M |
| Share Based Compensation | 534.00K |